PAMU
VPHM

Pictet Asset Management (UK)’s VIROPHARMA INC VPHM Stock Holding History

Pictet Asset Management (UK)’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-186,300
Closed -$7.32M – 899
2013
Q3 		$7.32M Sell
186,300
-76,500
-29% -$2.5M 0.04% 408
2013
Q2 		$7.53M Buy
+262,800
New +$6.93M 0.04% 384

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management (UK)'s VPHM Position: Q4 2013 in Review

Pictet Asset Management (UK) sold out of VIROPHARMA INC (VPHM) in Q4 2013, closing a stake of 186,300 shares — an estimated $7.32M sold.

Pictet Asset Management (UK) first reported a position in VPHM in Q2 2013 and held it in 2 quarters. The position peaked at $7.53M in Q2 2013. 172 funds tracked by Wall St. Rank hold VPHM as of Q4 2013.

  • Pictet Asset Management (UK) reported no remaining VIROPHARMA INC position as of Q4 2013 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 186,300 VIROPHARMA INC shares in Q4 2013, an estimated $7.32M.
  • Pictet Asset Management (UK) first reported a position in VIROPHARMA INC in Q2 2013 and held it in 2 quarters.
  • Pictet Asset Management (UK)'s VIROPHARMA INC position peaked at $7.53M in Q2 2013.
  • 172 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q4 2013.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2013, filed 14 Feb 2014.